Trial
NCT03606837
68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Bordeaux
Collaborators
—
Condition
Prostate Cancer
Intervention
68Ga-PSMA-617 PET/CT
Why stopped
target number of patients not reached
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23